NCT04924790 is a clinical trial of COVID-19 Pandemic in Urinary Stone, sponsored by Ankara Training and Research Hospital.

Who is sponsoring NCT04924790?

NCT04924790 is sponsored by Ankara Training and Research Hospital.

What drugs are being tested in NCT04924790?

Interventions in NCT04924790: COVID-19 Pandemic.

What condition does NCT04924790 study?

NCT04924790 studies Urinary Stone, Urinary Calculi, Covid19.

Is NCT04924790 still recruiting?

NCT04924790 is currently status unknown. Last updated 2 March 2022.

Last reviewed 2022-03-02 · How we verify

NCT04924790

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of the COVID-19 on Patient Preferences and Decision Making for Obstructive Urinary Stone Interventions

Status unknown Last updated 2 March 2022

What this trial tests

trial testing COVID-19 Pandemic in Urinary Stone in 158 participants. Status unknown.

Timeline

1 September 2021

Primary endpoint
1 May 2022

1 August 2022

Quick facts

Lead sponsor	Ankara Training and Research Hospital
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	158
Start date	1 September 2021
Primary completion	1 May 2022
Estimated completion	1 August 2022
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

COVID-19 Pandemic

Conditions studied

Urinary Stone — all drugs for Urinary Stone →
Urinary Calculi — all drugs for Urinary Calculi →
Covid19 — all drugs for Covid19 →

Sponsor

Ankara Training and Research Hospital

Who can join

Adults 18 to 90, any sex, with Urinary Stone or Urinary Calculi. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study, the investigators aim to evaluate the intervention preferences of patients with obstructive urinary stones who are suitable for operation during the COVID-19 pandemic. The secondary aim is to compare and evaluate the preferences compared to the pre-pandemic period and to gain a perspective on how the decision-making process has changed from the patient's point of view. Thus, by trying to understand how the COVID-19 epidemic affects the treatment choice decisions of patients, the investigators aim to determine how the state of anxiety changes these preferences.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

How has the COVID-19 pandemic changed treatment preferences of patients with proximal ureteral stones?
Yildiz AK, Varan A, Kurt H, Doluoglu OG, et al · · 2024 · cited 1× · PMID 38505151 · DOI 10.1097/cu9.0000000000000143

Verify or expand the search:

Other trials of COVID-19 Pandemic

Trials testing the same drug.

NCT04338672 — The Impact of the Covid-19 Outbreak on Emergency Room Attendances of Surgical Patients · unknown

Other recruiting trials for Urinary Stone

Currently open trials in the same condition.

NCT06628765 — Two Types of Single-use Flexible Ureteroscopies for the Treatment of Upper Urinary Tract Stones in Children · NA · recruiting
NCT06412900 — Radiomics and Image Segmentation of Urinary Stones by Artificial Intelligence · active not recruiting
NCT04796792 — Ultrasound to Facilitate Stone Passage · NA · recruiting

Other Ankara Training and Research Hospital trials

Trials by the same sponsor.

NCT07150455 — Evaluation of Myocardial Function by Global Longitudinal Strain (GLS) Measurement in 2D Echocardiography of Patients Wit · completed
NCT07467421 — "Effectiveness of Physical Therapy Added to Transforaminal Injection in Lumbar Radicular Pain" · NA · completed
NCT07143084 — Investigation of the Relationship Between Nutritional Status Assessment and Frailty in Critical Care Patients · enrolling by invitation
NCT07310667 — Assessing the Relationship Between Frailty and Skeletal Muscle Thickness in Critically Ill Patients · enrolling by invitation
NCT06946030 — Pseudoexfoliation and Carpal Tunnel Study · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04924790 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ankara Training and Research Hospital
Last refreshed: 2 March 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04924790.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing